Advertisement

Hereditary Risk for Cancer

  • Katherine S. Hunt

Keywords

Ovarian Cancer Genetic Testing Familial Adenomatous Polyposis BRCA2 Mutation BRCA2 Mutation Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1975). "Genetic counseling." Am J Hum Genet 27(2): 240–242.Google Scholar
  2. (1999). "Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium." J Natl Cancer Inst 91(15): 1310–1316.Google Scholar
  3. Aarnio, M., R. Sankila, et al. (1999). "Cancer risk in mutation carriers of DNA-mismatch-repair genes." Int J Cancer 81(2): 214–218.CrossRefPubMedGoogle Scholar
  4. ACOG (1997). "ACOG committee opinion. Breast-ovarian cancer screening. Number 176, October 1996. Committee on Genetics. The American College of Obstetricians and Gynecologists." Int J Gynaecol Obstet 56(1): 82–83.Google Scholar
  5. Amos, C., M. Frazie, T. McGarrity (2004). Peutz-Jeghers Syndrome. In GeneReviews. www.genetests.org, University of Washington, Accessed April 2, 2004.Google Scholar
  6. ASCO (2003). "American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility." J Clin Oncol 21(12): 2397–2406.Google Scholar
  7. ASHG (1994). "Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition." Am J Hum Genet 55(5): i–iv.Google Scholar
  8. Baker, L.H. (1982). "Breast Cancer Detection Demonstration Project: five-year summary report." CA Cancer J Clin 32(4): 194–225.PubMedGoogle Scholar
  9. Barnes-Kedar, I.M. and S.E. Plon (2002). "Counseling the at risk patient in the BRCA1 and BRCA2 Era." Obstet Gynecol Clin North Am 29(2): 341–366, vii.CrossRefPubMedGoogle Scholar
  10. Boardman, L.A., S.N. Thibodeau, et al. (1998). "Increased risk for cancer in patients with the Peutz-Jeghers syndrome." Ann Intern Med 128(11): 896–899.PubMedGoogle Scholar
  11. Brownstein, M.H., M. Wolf, et al. (1978). "Cowden's disease: a cutaneous marker of breast cancer." Cancer 41(6): 2393–2398.PubMedGoogle Scholar
  12. Burke, W., M. Daly, et al. (1997). "Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium." JAMA 277(12): 997–1003.CrossRefPubMedGoogle Scholar
  13. Claus, E.B., N. Risch, et al. (1994). "Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction." Cancer 73(3): 643–651.PubMedGoogle Scholar
  14. Couch, F.J., B.L. Weber, et al. (1996). "Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene." Human Mutation 8(1): 8–18.CrossRefPubMedGoogle Scholar
  15. Domchek, S.M., A. Eisen, et al. (2003). "Application of breast cancer risk prediction models in clinical practice." J Clin Oncol 21(4): 593–601.CrossRefPubMedGoogle Scholar
  16. Dunlop, M.G., S.M. Farrington, et al. (1997). "Cancer risk associated with germline DNA mismatch repair gene mutations." Hum Mol Genet 6(1): 105–110.CrossRefPubMedGoogle Scholar
  17. Eng, C. (2000). "Will the real Cowden syndrome please stand up: revised diagnostic criteria." J Med Genet 37(11): 828–830.CrossRefPubMedGoogle Scholar
  18. Fackenthal, J.D., D.J. Marsh, et al. (2001). "Male breast cancer in Cowden syndrome patients with germline PTEN mutations." J Med Genet 38(3): 159–164.CrossRefPubMedGoogle Scholar
  19. Fearon, E.R., B. Vogelstein (1990). "A genetic model for colorectal tumorigenesis." Cell 61(5): 759–767.CrossRefPubMedGoogle Scholar
  20. Ford, D., D.F. Easton, et al. (1994). "Risks of cancer in BRCA1-mutation carriers." Lancet 343(8899): 692–695.CrossRefPubMedGoogle Scholar
  21. Frank, T.S., S.A. Manley, et al. (1998). "Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk." J Clin Oncol 16(7): 2417–2425.PubMedGoogle Scholar
  22. Franks, L.M., Teich, N.M. (1997). Introduction to the Cellular and Molecular Biology of Cancer. London, Oxford University Press.Google Scholar
  23. Garber, J.E., A.M. Goldstein, et al. (1991). "Follow-up study of twenty-four families with Li-Fraumeni syndrome." Cancer Res 51(22): 6094–6097.PubMedGoogle Scholar
  24. Geller, G., J.R. Botkin, et al. (1997). "Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent." Jama 277(18): 1467–1474.CrossRefPubMedGoogle Scholar
  25. Giardiello, F.M., J.D. Brensinger, et al. (1997). "The use and interpretation of commercial APC gene testing for familial adenomatous polyposis." N Engl J Med 336(12): 823–827.CrossRefPubMedGoogle Scholar
  26. Hall, J.M., M.K. Lee, et al. (1990). "Linkage of early-onset familial breast cancer to chromo-some-17q21." Science 250(4988): 1684–1689.PubMedGoogle Scholar
  27. Hampel, H. and P. Peltomaki (2000). "Hereditary colorectal cancer: risk assessment and management." Clin Genet 58(2): 89–97.CrossRefPubMedGoogle Scholar
  28. Hartmann, L.C., T.A. Sellers, et al. (1999). "Clinical options for women at high risk for breast cancer." Surg Clin North Am 79(5): 1189–1206.CrossRefPubMedGoogle Scholar
  29. Hemminki, A. (1999). "The molecular basis and clinical aspects of Peutz-Jeghers syndrome." Cell Mol Life Sci 55(5): 735–750.CrossRefPubMedGoogle Scholar
  30. Hemminki, A., D. Markie, et al. (1998). "A serine/threonine kinase gene defective in Peutz-Jeghers syndrome." Nature 391(6663): 184–187.CrossRefPubMedGoogle Scholar
  31. Izatt, L., J. Greenman, et al. (1999). "Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer." Genes Chromosomes Cancer 26(4): 286–294.CrossRefPubMedGoogle Scholar
  32. Johannesdottir, G., J. Gudmundsson, et al. (1996). "High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients." Cancer Res 56(16): 3663–3665.PubMedGoogle Scholar
  33. King, J. E., R. R. Dozois, et al. (2000). "Care of patients and their families with familial adenomatous polyposis." Mayo Clin Proc 75(1): 57–67.PubMedGoogle Scholar
  34. King, M.C., J.H. Marks, et al. (2003). "Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2." Science 302(5645): 643–646.CrossRefPubMedGoogle Scholar
  35. Knudson, A.G. (1971). "Mutation and cancer — statistical study of retinoblastoma." Proceedings of the National Academy of Sciences of the United States of America 68(4): 820–823.PubMedGoogle Scholar
  36. Kohlman, W., Gruber, S.B. (2004). Hereditary Non-Polyposis Colon Cancer. In GeneReviews, www.genetests.org, accessed November 10, 2004.Google Scholar
  37. Kriege, M., C.T. Brekelmans, et al. (2004). "Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition." N Engl J Med 351(5): 427–437.PubMedGoogle Scholar
  38. Lerman, C., C. Hughes, et al. (2000). "Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing." Prev Med 31(1): 75–80.CrossRefPubMedGoogle Scholar
  39. Levine, A.J. (1997). "p53, the cellular gatekeeper for growth and division." Cell 88(3): 323–331.CrossRefPubMedGoogle Scholar
  40. Liede, A., B.Y. Karlan, et al. (2004). "Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature." J Clin Oncol 22(4): 735–742.CrossRefPubMedGoogle Scholar
  41. Lynch, H.T. and J.F. Lynch (1998). "Genetics of colonic cancer." Digestion 59(5): 481–492.CrossRefPubMedGoogle Scholar
  42. Lynch, H.T. and J.F. Lynch (2000). "Hereditary nonpolyposis colorectal cancer." Semin Surg Oncol 18(4): 305–313.CrossRefPubMedGoogle Scholar
  43. Malander, S., M. Ridderheim, et al. (2004). "One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden." European Journal of Cancer 40(3): 422–428.CrossRefPubMedGoogle Scholar
  44. Malkin, D., F.P. Li, et al. (1990). "Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms." Science 250(4985): 1233–1238.PubMedGoogle Scholar
  45. Miki, Y., J. Swensen, et al. (1994). "Isolation of BRCA1, the 17q-linked breast and ovarian cancer susceptibility gene." Science 266: 61–71.Google Scholar
  46. Narod, S.A., H. Risch, et al. (1998). "Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group." N Engl J Med 339(7): 424–428.CrossRefPubMedGoogle Scholar
  47. NCI (1998). Breast Cancer Risk Assessment Tool for Health Care Providers. N. C. I. Office of Cancer Communication, Bethesda.Google Scholar
  48. NCI (2004). Breast Cancer Risk Assessment Tool. http://bcra.nci.nih.gov/brc/, Accessed November 10, 2004.Google Scholar
  49. Nelen, M.R., G.W. Padberg, et al. (1996). "Localization of the gene for Cowden disease to chromosome 10q22–23." Nat Genet 13(1): 114–116.CrossRefPubMedGoogle Scholar
  50. NSGC (2004). National Society of Genetic Counselors Home Page. www.nsgc.org, Accessed November 10, 2004.Google Scholar
  51. Nussbaum, R.L., Mclnnes, R.R., Willard, H.F. (2001). Thompson and Thompson Genetics in Medicine. Philadelphia, W. B. Saunders Company.Google Scholar
  52. Offit, K. (1997). Clinical Cancer Genetics: Risk Counseling and Management. New York, Wiley-Liss.Google Scholar
  53. Parmigiani, G., D. Berry, et al. (1998). "Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2." Am J Hum Genet 62(1): 145–158.CrossRefPubMedGoogle Scholar
  54. Parmigiani, G., W. Wang (2004). BRCAPRO. B. Lab, http://astor.som.jhmi.edu/BayesMendel/brcapro.html, accessed November 10, 2004.Google Scholar
  55. Peelen, T., W. de Leeuw, et al. (2000). "Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis." Int J Cancer 88(5): 778–782.CrossRefPubMedGoogle Scholar
  56. Peelen, T., M. vanVliet, et al. (1997). "A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families." American Journal of Human Genetics 60(5): 1041–1049.PubMedGoogle Scholar
  57. Peltomaki, P. and H.F. Vasen (1997). "Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer." Gastroenterology 113(4): 1146–1158.CrossRefPubMedGoogle Scholar
  58. Peters, J.A. and J.E. Stopfer (1996). "Role of the genetic counselor in familial cancer." Oncology (Huntingt) 10(2): 159–166.Google Scholar
  59. Petrij-Bosch, A., T. Peelen, et al. (1997). "BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients." Nat Genet 17(3): 341–345.PubMedGoogle Scholar
  60. Rebbeck, T.R., T. Friebel, et al. (2004). "Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group." J Clin Oncol 22(6): 1055–1062.CrossRefPubMedGoogle Scholar
  61. Risch, H.A., J.R. McLaughlin, et al. (2001). "Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer." Am J Hum Genet 68(3): 700–710.CrossRefPubMedGoogle Scholar
  62. Savitsky, K., S. Sfez, et al. (1995). "The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species." Hum Mol Genet 4(11): 2025–2032.PubMedGoogle Scholar
  63. Schneider, K. (2001). Counseling About Cancer: Strategies for Genetic Counseling. New York, Wiley-Liss.Google Scholar
  64. Schrag, D., K.M. Kuntz, et al. (1997). "Decision analysis — effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations." N Engl J Med 336(20): 1465–1471.CrossRefPubMedGoogle Scholar
  65. Shattuck-Eidens, D., A. Oliphant, et al. (1997). "BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing." JAMA 278(15): 1242–1250.CrossRefPubMedGoogle Scholar
  66. Solomon, C., Burt, R.W. (2004). Familial adenomatous polyposis. In GeneReviews. www.gene-tests.org, University of Washington, Accessed April 2, 2004.Google Scholar
  67. Struewing, J.P., P. Hartge, et al. (1997). "The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews." N Engl J Med 336(20): 1401–1408.CrossRefPubMedGoogle Scholar
  68. Swift, M., D. Morrell, et al. (1991). "Incidence of cancer in 161 families affected by ataxia-telangiectasia." N Engl J Med 325(26): 1831–1836.PubMedGoogle Scholar
  69. Thompson, D., D. Easton, et al. (2001). "Variation in cancer risks, by mutation position, in BRCA2 mutation carriers." American Journal of Human Genetics 68(2): 410–419.CrossRefPubMedGoogle Scholar
  70. Thull, D.L. and V.G. Vogel (2004). "Recognition and management of hereditary breast cancer syndromes." Oncologist 9(1): 13–24.CrossRefPubMedGoogle Scholar
  71. Tirkkonen, M., O. Johannsson, et al. (1997). "Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations." Cancer Research 57(7): 1222–1227.PubMedGoogle Scholar
  72. Tonin, P., B. Weber, et al. (1996). "Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families." Nature Medicine 2(11): 1179–1183.CrossRefPubMedGoogle Scholar
  73. Tyrer, J., S.W. Duffy, et al. (2004). "A breast cancer prediction model incorporating familial and personal risk factors." Stat Med 23(7): 1111–1130.CrossRefPubMedGoogle Scholar
  74. Umar, A., C.R. Boland, et al. (2004). "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability." J Natl Cancer Inst 96(4): 261–268.PubMedGoogle Scholar
  75. Vasen, H.F., M. van Ballegooijen, et al. (1998). "A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers." Cancer 82(9): 1632–1637.CrossRefPubMedGoogle Scholar
  76. Vogelstein, B., Kinzler, K.W. (2002). The Genetic Basis of Human Cancer. New York, McGraw-Hill Professional.Google Scholar
  77. Warner, E., D.B. Plewes, et al. (2004). "Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination." JAMA 292(11): 1317–1325.CrossRefPubMedGoogle Scholar
  78. Watanabe, T., T.T. Wu, et al. (2001). "Molecular predictors of survival after adjuvant chemotherapy for colon cancer." N Engl J Med 344(16): 1196–1206.CrossRefPubMedGoogle Scholar
  79. Weber, T. (1996). "Clinical surveillance recommendations adopted for HNPCC." Lancet 348: 465.CrossRefGoogle Scholar
  80. Wijnen, J.T., H.F. Vasen, et al. (1998). "Clinical findings with implications for genetic testing in families with clustering of colorectal cancer." N Engl J Med 339(8): 511–518.CrossRefPubMedGoogle Scholar
  81. Wooster, R., G. Bignell, et al. (1995). "Identification of the Breast-Cancer Susceptibility Gene Brca2." Nature 378(6559): 789–792.CrossRefPubMedGoogle Scholar
  82. Ylikorkala, A., E. Avizienyte, et al. (1999). "Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer." Hum Mol Genet 8(1): 45–51.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2005

Authors and Affiliations

  • Katherine S. Hunt
    • 1
  1. 1.Mayo Clinic-ScottsdaleScottsdale

Personalised recommendations